Published:
WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
SHANGHAI, China, Jan. 6 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.
(NYSE: WX), a leading pharmaceutical, biotechnology, and medical device
research and development outsourcing company with operations inChina andthe
United States, today announced that Dr. Ge Li, the Company's Chairman and
Chief Executive Officer, will present at the 27th Annual J.P. Morgan
Healthcare Conference on Tuesday, January 13, 2009, at 4:30 pm Pacific
Standard Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The Company will broadcast its presentation. The public may access the
broadcast through the Investor Relations section of the Company's web site:
http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical
device R&D outsourcing company, with operations inChina andthe United States.
As a research-driven and customer-focused company, WuXi PharmaTech provides a
broad and integrated portfolio of laboratory and manufacturing services
throughout the drug and medical device R&D process. WuXi PharmaTech's
services are designed to assist its global partners in shortening the cycle
and lowering the cost of drug and medical device R&D. WuXi PharmaTech's
operating subsidiaries are known as WuXi AppTec. For more information, please
visit: http://www.wuxiapptec.com .
For more information, please contact:
Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-215-218-5515
Email: Ron_Aldridge@wuxiapptec.com
Juliane Snowden
Vice President of Investor Relations
Burns McClellan
Tel: +1-212-213-0006
Email: Jsnowden@burnsmc.com
Web: http://www.wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,BIO,HEA,MTC,TDS,WX-Healthcare-Conf
Search News
Daily News
